Advanced Biomed (ADVB) Accumulated Expenses (2024 - 2026)

Advanced Biomed has disclosed Accumulated Expenses across 3 years of filings, most recently posting $68245.0 for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $68245.0, down 37.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $68245.0 (down 37.13% YoY), and the FY2025 annual result was $575831.0, up 646.74% from the prior year.
• Accumulated Expenses came in at $68245.0 for Q1 2026 at Advanced Biomed, down from $224038.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $575831.0 in Q2 2025 to a low of $68245.0 in Q1 2026.
• The 3-year median for Accumulated Expenses is $108548.0 (2025), against an average of $181771.9.
• Across the five-year window, Accumulated Expenses surged 646.74% in 2025 and tumbled 37.13% in 2026, its largest moves.
• Advanced Biomed's Accumulated Expenses stood at $145295.0 in 2024, then jumped by 54.2% to $224038.0 in 2025, then plunged by 69.54% to $68245.0 in 2026.
• The last three Accumulated Expenses figures came in at $68245.0 (Q1 2026), $224038.0 (Q4 2025), and $73333.0 (Q3 2025), per Business Quant data.